Author contribution: Bomshteyn NG, Bolotov YuV — study concept and design, data acquisition and processing, manuscript writing; Kim IA, Trukhin DV — study management, manuscript editing.
Compliance with ethical standards: the study was approved by the Ethics Committee of the Scientific and Clinical Center of Otorhinolaryngology of the Federal Medico-Biological Agency of the Russian Federation (protocol № 02/20 dated April 13, 2020). All patients submitted the informed consent to participation in the study.
Published online: 2020-12-15
Vremennye metodicheskie rekomendacii «Profilaktika, diagnostika i lechenie novoj koronavirusnoj infekcii (COVID-19)». Ministerstvo zdravoohranenija Rossijskoj Federacii. Versija 6, 2020; 164 s. Russian.
Conte L, Maurizio Toraldo D. Targeting the gut–lung microbiota axis by means of a high-fibre diet and probiotics may have anti-inflammatory effects in COVID-19 infection. Ther Adv Respir Dis. 2020; 14: 1–5. DOI: 10.1177/1753466620937170 39.
Bomshteyn NG, Bolotov YV, Kim IA, Trukhin DV.
Effectiveness of immobilized probiotics for complex therapy of novel coronavirus infection COVID-19 in hospital settings.
Bomshteyn, N. G., Bolotov, Y. V., Kim, I. A. and Trukhin, D. V. (2020),
"Effectiveness of immobilized probiotics for complex therapy of novel coronavirus infection COVID-19 in hospital settings",